{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:02:50Z","timestamp":1788850970514,"version":"build-2803163510"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011772","name":"Novartis Farmac\u00e9utica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Epithelial-mesenchymal transition (EMT) is a dynamic process by which epithelial cells loss their phenotype and acquire mesenchymal traits, including increased migratory and invasive capacities. EMT is involved in physiological processes, such as embryogenesis and wound healing, and in pathological processes such as cancer, playing a pivotal role in tumor progression and metastasis. Pituitary tumors, although typically benign, can be locally invasive. Different studies have shown the association of EMT with increased tumor size and invasion in pituitary tumors, and in particular with a poor response to Somatostatin Receptor Ligands (SRLs) treatment in GH-producing pituitary tumors, the main cause of acromegaly. This review will summarize the current knowledge regarding EMT and SRLs resistance in acromegaly and, based on this relation, will suggest new biomarkers and possible therapies to SRLs resistant tumors.<\/jats:p>","DOI":"10.3389\/fendo.2021.646210","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T13:35:04Z","timestamp":1615815304000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Epithelial\u2013Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly"],"prefix":"10.3389","volume":"12","author":[{"given":"Joan","family":"Gil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Jord\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Soldevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Puig-Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial\u2013mesenchymal transition","volume":"6","author":"Yang","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT Transition States during Tumor Progression and Metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0196-y","article-title":"Non-redundant functions of EMT transcription factors","volume":"21","author":"Stemmler","year":"2019","journal-title":"Nat Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1760","article-title":"Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly","volume":"97","author":"Lekva","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1051","article-title":"Epithelial Splicing Regulator Protein 1 and Alternative Splicing in Somatotroph Adenomas","volume":"154","author":"Lekva","year":"2013","journal-title":"Endocrinology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-18-0565","article-title":"Molecular profiling for acromegaly treatment: a validation study","volume":"27","author":"Puig-Domingo","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e66927","DOI":"10.1371\/journal.pone.0066927","article-title":"Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recovery","volume":"8","author":"Lekva","year":"2013","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-12-0229","article-title":"Pituitary development: a complex, temporal regulated process dependent on specific transcriptional factors","volume":"215","author":"de Moraes","year":"2012","journal-title":"J Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/1043-2760(94)00090-Q","article-title":"Embryology of the pituitary gland","volume":"6","author":"Dubois","year":"1995","journal-title":"Trends Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.14470","article-title":"PROP1 triggers epithelial-mesenchymal transition-like process in pituitary stem cells","volume":"5","author":"P\u00e9rez Mill\u00e1n","year":"2016","journal-title":"Elife"},{"key":"B13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mce.2016.09.016","article-title":"Regulation of pituitary stem cells by epithelial to mesenchymal transition events and signaling pathways","volume":"445","author":"Cheung","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1038\/s41467-020-19012-4","article-title":"Single-cell transcriptomics identifies divergent developmental lineage trajectories during human pituitary development","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1267\/ahc.10001","article-title":"Effect of E-cadherin Expression on Hormone Production in Rat Anterior Pituitary Lactotrophs In Vitro","volume":"43","author":"Kusumoto","year":"2010","journal-title":"Acta Histochem Cytochem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa281","article-title":"FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors","volume":"105","author":"Kolnes","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028738","article-title":"Integration of Cadherin Adhesion and Cytoskeleton at Adherens Junctions","volume":"9","author":"M\u00e8ge","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12340","article-title":"From cell membrane to the nucleus: an emerging role of E-cadherin in gene transcriptional regulation","volume":"18","author":"Du","year":"2014","journal-title":"J Cell Mol Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2075","article-title":"Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas","volume":"94","author":"Elston","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000039572.75188.1A","article-title":"Role of E-Cadherin, \u03b1-, \u03b2-, and \u03b3-Catenins, and p120 (Cell Adhesion Molecules) in Prolactinoma Behavior","volume":"15","author":"Qian","year":"2002","journal-title":"Mod Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12352","article-title":"Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas","volume":"28","author":"Chauvet","year":"2016","journal-title":"J Neuroendocrinol"},{"key":"B22","article-title":"Epithelial-mesenchymal Transition (EMT) Markers in Human Pituitary Adenomas Indicate a Clinical Course","volume":"35","author":"Jia","year":"2015","journal-title":"Anticancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/1066896912471850","article-title":"Expression and Significance of E-Cadherin and \u03b2-Catenins in Pituitary Adenoma","volume":"21","author":"Zhou","year":"2013","journal-title":"Int J Surg Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20176808","article-title":"Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly","volume":"51","author":"Mendes","year":"2018","journal-title":"Braz J Med Biol Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.11.034","article-title":"ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR\/ERK signaling pathway","volume":"97","author":"Wang","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1530\/EJE-17-0702","article-title":"Gene expression profiling of fast- and slow-growing non-functioning gonadotroph pituitary adenomas","volume":"178","author":"Falch","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.9b00914","article-title":"Diagnosis of Invasive Nonfunctional Pituitary Adenomas by Serum Extracellular Vesicles","volume":"91","author":"Wang","year":"2019","journal-title":"Anal Chem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.48","article-title":"PTTG2 silencing results in induction of epithelial-to-mesenchymal transition and apoptosis","volume":"4","author":"M\u00e9ndez-Vidal","year":"2013","journal-title":"Cell Death Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.18632\/aging.104072","article-title":"Intracellular and extracellular S100A9 trigger epithelial-mesenchymal transition and promote the invasive phenotype of pituitary adenoma through activation of AKT1","volume":"12","author":"Huang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.11.002","article-title":"Pangenomic Classification of Pituitary Neuroendocrine Tumors","volume":"37","author":"Neou","year":"2020","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10847","article-title":"Regulating the CCNB1 gene can affect cell proliferation and apoptosis in pituitary adenomas and activate epithelial\u2212to\u2212mesenchymal transition","volume":"18","author":"Li","year":"2019","journal-title":"Oncol Lett"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1515\/chem-2018-0061","article-title":"Epithelial\u2013Mesenchymal Transition Induced by SMAD4 Activation in Invasive Growth Hormone-Secreting Adenomas","volume":"16","author":"Shan","year":"2018","journal-title":"Open Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102300","article-title":"COL6A6 interacted with P4HA3 to suppress the growth and metastasis of pituitary adenoma via blocking PI3K-Akt pathway","volume":"11","author":"Long","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-020-09570-0","article-title":"Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas","volume":"1","author":"Zhao","year":"2021","journal-title":"Cell Biol Toxicol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.10.003","article-title":"MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5","volume":"356","author":"Renjie","year":"2015","journal-title":"Cancer Lett"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.567021","article-title":"JAG1, Regulated by microRNA-424-3p, Involved in Tumorigenesis and Epithelial\u2013Mesenchymal Transition of High Proliferative Potential-Pituitary Adenomas","volume":"10","author":"Chen","year":"2020","journal-title":"Front Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2020.3587","article-title":"LncRNA SNHG6 Induces Epithelial\u2013Mesenchymal Transition of Pituitary Adenoma Via Suppressing MiR-944","author":"Mao","year":"2020","journal-title":"Cancer Biother Radiopharm"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.917110","article-title":"Long Non-Coding RNA Plasmacytoma Variant Translocation 1 (PVT1) Enhances Proliferation, Migration, and Epithelial-Mesenchymal Transition (EMT) of Pituitary Adenoma Cells by Activating \u03b2-Catenin, c-Myc, and Cyclin D1 Expression","volume":"25","author":"Zhang","year":"2019","journal-title":"Med Sci Monit"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1159\/000492089","article-title":"Lnc-SNHG1 Activates the TGFBR2\/SMAD3 and RAB11A\/Wnt\/\u03b2-Catenin Pathway by Sponging MiR-302\/372\/373\/520 in Invasive Pituitary Tumors","volume":"48","author":"Wang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5050051","article-title":"Tumor Budding: The Name is EMT. Partial EMT","volume":"5","author":"Grigore","year":"2016","journal-title":"J Clin Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0779-5","article-title":"Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors","volume":"38","author":"Barry","year":"2019","journal-title":"Oncogene"},{"key":"B42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s40478-019-0830-3","article-title":"Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours","volume":"7","author":"Marques","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-19-0327","article-title":"Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness","volume":"26","author":"Marques","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1111","article-title":"Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway","volume":"97","author":"Chahal","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-17-0254","article-title":"AIP and the somatostatin system in pituitary tumours","volume":"235","author":"Ib\u00e1\u00f1ez-Costa","year":"2017","journal-title":"J Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0791-0","article-title":"Somatostatin receptor ligands in the treatment of acromegaly","volume":"20","author":"Gadelha","year":"2017","journal-title":"Pituitary"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2009.12.003","article-title":"Pituitary somatostatin receptor signaling","volume":"21","author":"Ben-Shlomo","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1530\/EJE-07-0562","article-title":"Quantitative analysis of somatostatin receptor subtypes (1\u20135) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR","volume":"158","author":"Taboada","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1210\/er.2010-0002","article-title":"Resistance to Somatostatin Analogs in Acromegaly","volume":"32","author":"Colao","year":"2011","journal-title":"Endocr Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2012.11.007","article-title":"Novel pathway for somatostatin analogs in patients with acromegaly","volume":"24","author":"Gadelha","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8050676","article-title":"Contribution of Epithelial Plasticity to Therapy Resistance","volume":"8","author":"Santamar\u00eda","year":"2019","journal-title":"J Clin Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2197","article-title":"The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response","volume":"95","author":"Fougner","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13851","article-title":"E-cadherin expression is associated with somatostatin analogue response in acromegaly","volume":"23","author":"Venegas-Moreno","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1365-2265.2011.04163.x","article-title":"Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly","volume":"76","author":"Fougner","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0383-y","article-title":"Growth hormone tumor histological subtypes predict response to surgical and medical therapy","volume":"49","author":"Kiseljak-Vassiliades","year":"2015","journal-title":"Endocrine"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800965","article-title":"Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas","volume":"20","author":"Qian","year":"2007","journal-title":"Mod Pathol"},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.1159\/000079041","article-title":"Down-Regulation of E-Cadherin and Catenins in Human Pituitary Growth Hormone-Producing Adenomas","volume-title":"Molecular Pathology of the Pituitary","author":"Sano","year":"2004"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1385\/EP:13:4:341","article-title":"Downregulation of E-Cadherin and Its Undercoat Proteins in Pituitary Growth Hormone Cell Adenomas with Prominent Fibrous Bodies","volume":"13","author":"Xu","year":"2002","journal-title":"Endocr Pathol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-016-0770-x","article-title":"Effects of somatostatin and its analogues on progenitor mesenchymal cells isolated from human pituitary adenomas","volume":"20","author":"Orciani","year":"2017","journal-title":"Pituitary"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2013\/5755.2954","article-title":"Shrestha BL. E-cadherin expression: a diagnostic utility for differentiating breast carcinomas with ductal and lobular morphologies","volume":"7","author":"Pai","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-020-09646-x","article-title":"Structure, Function, and Morphology in the Classification of Pituitary Neuroendocrine Tumors: the Importance of Routine Analysis of Pituitary Transcription Factors","volume":"4","author":"Mete","year":"2020","journal-title":"Endocr Pathol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2010.195","article-title":"An ESRP-regulated splicing programme is abrogated during the epithelial\u2013mesenchymal transition","volume":"29","author":"Warzecha","year":"2010","journal-title":"EMBO J"},{"key":"B63","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.canlet.2015.01.037","article-title":"Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas","volume":"359","author":"Luque","year":"2015","journal-title":"Cancer Lett"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/srep08714","article-title":"In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features","volume":"5","author":"Ib\u00e1\u00f1ez-Costa","year":"2015","journal-title":"Sci Rep"},{"key":"B65","article-title":"Alternative splicing of placental lactogen (CSH2) in somatotroph pituitary adenomas","volume":"36","author":"Lekva","year":"2015","journal-title":"Neuro Endocrinol Lett"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14339","article-title":"Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH producing adenomas","author":"Gil","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3892\/br.2015.494","article-title":"Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression","volume":"3","author":"Sun","year":"2015","journal-title":"BioMed Rep"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1104211108","article-title":"RefilinB (FAM101B) targets FilaminA to organize perinuclear actin networks and regulates nuclear shape","volume":"108","author":"Gay","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4161\/bioa.18246","article-title":"Refilins","volume":"1","author":"Gay","year":"2011","journal-title":"Bioarchitecture"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-257345","article-title":"SNAIL-induced epithelial-to-mesenchymal transition produces concerted biophysical changes from altered cytoskeletal gene expression","volume":"29","author":"McGrail","year":"2015","journal-title":"FASEB J"},{"key":"B71","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/ERC-18-0442","article-title":"Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors","volume":"26","author":"Mantovani","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41598-018-37692-3","article-title":"Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles","volume":"9","author":"Coelho","year":"2019","journal-title":"Sci Rep"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1159\/000503791","article-title":"Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph Cells","volume":"110","author":"Treppiedi","year":"2020","journal-title":"Neuroendocrinology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00187","article-title":"Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement","volume":"6","author":"Peverelli","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pharmthera.2017.08.009","article-title":"EMT: Mechanisms and therapeutic implications","volume":"182","author":"Singh","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00027-3","article-title":"Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial","volume":"16","author":"Kordes","year":"2015","journal-title":"Lancet Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.04.007","article-title":"Unmasking a new prognostic marker and therapeutic target from the GDNF-RET\/PIT1\/p14ARF\/p53 pathway in acromegaly","volume":"43","author":"Chenlo","year":"2019","journal-title":"EBioMedicine"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.13","article-title":"Epithelial\u2013mesenchymal transition: a new target in anticancer drug discovery","volume":"15","author":"Marcucci","year":"2016","journal-title":"Nat Rev Drug Discovery"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.409","article-title":"Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells","volume":"31","author":"Yue","year":"2012","journal-title":"Oncogene"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604794","article-title":"Cross talk of signals between EGFR and IL-6R through JAK2\/STAT3 mediate epithelial\u2013mesenchymal transition in ovarian carcinomas","volume":"100","author":"Colomiere","year":"2009","journal-title":"Br J Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2014.2439","article-title":"Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line","volume":"45","author":"Ashizawa","year":"2014","journal-title":"Int J Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78173","article-title":"STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion","volume":"125","author":"Zhou","year":"2015","journal-title":"J Clin Invest"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01000","article-title":"Growth Hormone and the Epithelial-to-Mesenchymal Transition","volume":"102","author":"Brittain","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000186","article-title":"Growth hormone in the tumor microenvironment","volume":"63","author":"Chesnokova","year":"2020","journal-title":"Arch Endocrinol Metab"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1600561113","article-title":"Growth hormone is permissive for neoplastic colon growth","volume":"113","author":"Chesnokova","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404208","article-title":"Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients","volume":"6","author":"Tan","year":"2014","journal-title":"EMBO Mol Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100204","article-title":"Personalized Medicine: Elusive Dream or Imminent Reality","volume":"81","author":"Lesko","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"B88","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1530\/EJE-17-1006","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the treatment of acromegaly","volume":"178","author":"Kasuki","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/cen.12731","article-title":"Treatment of acromegaly in the era of personalized and predictive medicine","volume":"83","author":"Puig Domingo","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cen.12797","article-title":"A paradigm shift in the medical treatment of acromegaly: from a \u201ctrial and error\u201d to a personalized therapeutic decision-making process","volume":"83","author":"Gadelha","year":"2015","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.646210\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T13:35:11Z","timestamp":1615815311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.646210\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":90,"alternative-id":["10.3389\/fendo.2021.646210"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.646210","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"article-number":"646210"}}